This inventor holds 1 USPTO granted patent. Top assignee: Eromlife Co., Ltd.. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007
Title: The Innovations of Suk Gyu Woo
Introduction
Suk Gyu Woo is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of microbiology, particularly through his innovative research on novel microorganisms. His work focuses on enhancing immune functions and developing applications for health and wellness.
Latest Patents
Suk Gyu Woo holds a patent for a novel genus microorganism known as EROM101 (KCCM-10517). This microorganism, which originates from human intestines, exhibits immune enhancement, anticancer, and antiviral activities. The patent outlines the potential uses of EROM101 in various products, including immune enhancement agents, anticancer agents, antimicrobial agents, food additives, intestinal function-controlling agents, live bacterial agents, feed additives, and other fermented products. This innovation highlights the importance of gut health and its impact on overall well-being.
Career Highlights
Suk Gyu Woo is associated with Eromlife Co., Ltd., a company dedicated to advancing health through innovative microbiological solutions. His work has positioned him as a key figure in the development of products that leverage the benefits of beneficial microorganisms. His research has the potential to transform health products and improve quality of life.
Collaborations
Suk Gyu Woo collaborates with talented individuals in his field, including Chang Won Choi and Mi Hyoun Park. Their combined expertise contributes to the advancement of research and development in microbiology and health-related applications.
Conclusion
Suk Gyu Woo's contributions to the field of microbiology through his patent on EROM101 demonstrate the potential of novel microorganisms in enhancing health. His work at Eromlife Co., Ltd. and collaborations with fellow researchers further emphasize the importance of innovation in this vital area of science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile